On January 23, 2015, the chief negotiators of the TPP are meeting in what could be the final opportunity for Canada to stand strong against intellectual property (IP) rules that would limit generic competition that reduces drug prices and improve access to treatment. It is important that Canada rejects provisions being proposed in the Trans-Pacific Partnership (TPP) Agreement that will make it harder for those in developing countries to access affordable generic medicines.
Please consider signing MSF petition if you have not already done so and share with your network. Medicines should not be a luxury. To sign the petition, please go to http://campaigns.msf.ca/tpp